ALAMEDA, Calif., Nov. 29, 2018 /PRNewswire/ -- Penumbra, Inc.
(NYSE: PEN) today announced that its management team is
scheduled to present at the BMO Prescriptions for Success
Healthcare Conference in New York,
NY on Wednesday, December 12,
2018.
|
Event:
|
BMO Prescriptions for
Success Healthcare Conference
|
|
Date:
|
Wednesday, December
12, 2018
|
|
Time:
|
10:40am ET / 7:40am
PT
|
A webcast of the presentation will be available by visiting the
investors section of the company's website at www.penumbrainc.com.
The webcast will be available on the company's website for
two weeks following the event.
About Penumbra
Penumbra, Inc., headquartered in Alameda, California, is a global healthcare
company focused on innovative therapies. Penumbra designs,
develops, manufactures and markets medical devices and has a broad
portfolio of products that addresses challenging medical conditions
and significant clinical needs. Penumbra sells its products
to hospitals primarily through its direct sales organization in
the United States, most of
Europe, Canada and Australia, and through distributors in select
international markets. The Penumbra P logo is a trademark of
Penumbra, Inc. For more information,
visit www.penumbrainc.com.
Investor Relations
Penumbra, Inc.
510-995-2461
investors@penumbrainc.com
Source: Penumbra, Inc.
View original content to download
multimedia:http://www.prnewswire.com/news-releases/penumbra-inc-to-present-at-the-bmo-prescriptions-for-success-healthcare-conference-300757592.html
SOURCE Penumbra, Inc.